Volume 69 Received 6 November 2012 | ||||||||||
| ||||||||||
-Hydroxy-17
-methylandrosta-1,4-dien-3-oneaSchool of Chemistry, National University of Ireland, Galway, University Road, Galway, Ireland
Correspondence e-mail: patrick.mcardle@nuigalway.ie
The title compound, C20H28O2, is a steroid with strong anabolic properties. The present solvent-free form crystallizes with two molecules per asymmetric unit. In the crystal, both molecules are involved in the formation of O-H
O hydrogen-bonded chains which extend along the b-axis direction.
For examples of other compounds with unused hydrogen-bonding capacity, see: Bhatt et al. (2006
); Lewis et al. (2005
); Desiraju et al. (2002
). For related structures of other anabolic steroids, see: Verma et al. (2006
). For related structures of steroid compounds with non-hydrogen-bonded OH or C=O motifs, see: Karpinska et al. (2011
); Danaci et al. (1988
); Chakrabarti et al. (1981
); McPhail et al. (1977
); Delettré et al. (1975
). For applications of methandrostenolone, see: Druzhinina et al. (2008
). For a previously reported mono hydrate (with no unused hydrogen-bonding capacity), see: Duax et al. (1982
).
|
|
| ||||||||||||||||||||||
Data collection: CrysAlis171 (Oxford Diffraction, 2010
); cell refinement: CrysAlis171; data reduction: CrysAlis171; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEX (McArdle, 1995
); software used to prepare material for publication: CIFTAB (Sheldrick, 2008
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: BG2491 ).
The authors thank the Science Foundation Ireland (SFI) for funding for the Solid State Pharmaceuticals Cluster (SSPC).
Bhatt, P. M. & Desiraju, G. R. (2006). Acta Cryst. C62, o362-o363.
![[details]](../../../../../../c/graphics/details.gif)
Chakrabarti, P., Banerjee, D. K. & Venkatesan, K. (1981). Steroids, 37, 269-279.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Danaci, S., Kendi, E., Moers, F. G., Behm, H. & Beurskens, P. T. (1988). Acta Cryst. C44, 1677-1679.
![[details]](../../../../../../c/graphics/details.gif)
Delettré, J., Mornon, J.-P. & Lepicard, G. (1975). Acta Cryst. B31, 450-453.
![[ISI]](../../../../../../logos/isiborder.gif)
Desiraju, G. R. (2002). CrystEngComm, 4, 499-499.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Druzhinina, A., Andryushina, V., Stytsenko, T. & Voishvillo, N. (2008). Appl. Biochem. Microbiol. 44, 580-584.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Duax, W. L., Rohrer, D. C. & Segaloff, A. (1982). Acta Cryst. B38, 531-534.
![[details]](../../../../../../b/graphics/details.gif)
Karpinska, J., Erxleben, A. & McArdle, P. (2011). Cryst. Growth Des. 11, 2829-2838.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Lewis, T. C., Tocher, D. A. & Price, S. L. (2005). Cryst. Growth Des. 5, 983-993.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
McArdle, P. (1995). J. Appl. Cryst. 28, 65.
![[details]](../../../../../../j/graphics/details.gif)
McPhail, A. T., Luhan, P. A., Tschang, P.-S. W. & Onan, K. D. (1977). J. Chem. Soc. Perkin Trans. 2, pp. 379-383.
Oxford Diffraction (2010). CrysAlis171. Oxford Diffraction Ltd, Yarnton, England.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Verma, R., Jasrotia, D. & Bhat, M. (2006). J. Chem. Crystallogr. 36, 283-287.
![[ChemPort]](../../../../../../logos/chemportborder.gif)